[Retracted] Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies

Figure 6

Association of the 5-IR-DEG risk model and predicted responses to immune checkpoint blocker therapy. (a) Overall correlation between model score and TIDE score; (b) correlation between model score and TIDE score in the high-risk group; (c) correlation between model score and TIDE score in the low-risk group; (d) ROC curve when using the model score to predict responders of low-risk subjects.

(a)

(b)

(c)

(d)